Inhibitors of TWIST1 are not available; therefore, to investigate the therapeutic relevance of inhibiting TWIST1 in GBM we knocked down TWIST1 expression using shRNA and assayed its effects on cell invasion and glioma stem cell properties. The gene discussed is TWIST1; the disease is glioma.